Repurposing the Antidepressant Sertraline as SHMT Inhibitor to Suppress Serine/Glycine Synthesis-Addicted Breast Tumor Growth

S.L. Geeraerts, K.R. Kampen, G. Rinaldi, P. Gupta, M. Planque, N. Louros, E. Heylen, K. De Cremer, K. De Brucker, S. Vereecke, B. Verbelen, P. Vermeersch, J. Schymkowitz, F. Rousseau, D. Cassiman, S.M. Fendt, A. Voet, B.P.A. Cammue, K. Thevissen*, K. De Keersmaecker*

*Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review

Fingerprint

Dive into the research topics of 'Repurposing the Antidepressant Sertraline as SHMT Inhibitor to Suppress Serine/Glycine Synthesis-Addicted Breast Tumor Growth'. Together they form a unique fingerprint.

Keyphrases

INIS

Pharmacology, Toxicology and Pharmaceutical Science

Biochemistry, Genetics and Molecular Biology